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background:  Cardiovascular disease has emerged as a major source of morbidity and mortality for patients with human 
immunodeficiency virus (HIV). While the association is well established, there are limited data describing the clinical and procedural 
characteristics of HIV(+) patients presenting with acute coronary syndrome (ACS).
methods:  We retrospectively reviewed records of patients admitted to Emory University Hospital and Emory University Hospital Midtown 
with ACS from 2006 to 2012 for documented HIV infection. Coronary artery disease (CAD) risk factors and catheterization data were 
compared to gender- and race-matched HIV(-) patients admitted with ACS from the same hospitals and time period.
Results:  The 86 HIV(+) and 318 HIV(-) matched controls presenting with ACS were similar in terms of gender (male: 84% vs 77%), race 
(African American: 62% vs 65%), hypertension (84% vs 77%), diabetes (27% vs 35%) and tobacco use (71% vs 69%). HIV(+) patients 
were, however, younger (52 vs 60 years, p < 0.001), less overweight (BMI 24.5 vs 30.5 kg/m2, p < 0.001) and had lower Framingham 
risk than their matched cohort (9.9% vs 12.9%, p < 0.01). HIV(+) patients had a mean CD4 count of 371 cells/μL, and 75% were on 
antiretroviral therapy. Compared to controls, HIV(+) patients presented more frequently with ST elevation myocardial infarction (STEMI) 
(29% vs 11%, p < 0.001). They had similar rates of non-ST elevation myocardial infarction (58% vs 72%) and unstable angina (17% vs 
13%). Among HIV(+) patients, 27% received medical therapy, 55% percutaneous coronary intervention, and 20% coronary artery bypass 
graft (CABG); among controls, 35% received medical therapy, 56% percutaneous intervention, and 9% CABG (p < 0.01). The severity of 
CAD measured by the Gensini score for both groups was similar (52.8 vs 52.6), with fewer vessels involved (2.2 vs 2.5, p = 0.015) in the 
HIV(+) group.
conclusion:  HIV(+) patients presenting with ACS have a similar burden of CAD as HIV(-) patients, despite younger age and a lower 
Framingham risk score. These patients also may be more susceptible to STEMI and need for CABG. Further studies are warranted to 
confirm these findings and ways to reduce this risk.
